(Q28326986)

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

18 May 2023

1 reference

R. Batey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A451459

18 May 2023

J. Scott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A451459

18 May 2023

S. Jain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A451459

18 May 2023

S. Sherlock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A451459

full work available at URL

18 May 2023

language of work or name

English

0 references

publication date

March 1979

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0609.1979.tb02809.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1979.tb02809.x/fullpdf

18 May 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Scandinavian Journal of Haematology

18 May 2023

published in

0 references

volume

22

0 references

issue

3

0 references

page(s)

277-9

0 references

cites work

Desferrioxamine B: reversible side effects of high daily doses

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Iron chelation therapy with deferoxamine in Cooley anemia

18 May 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Excretion of iron in response to deferoxamine in sickle cell anemia

18 May 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Treatment of iron overload in adults with continuous parenteral desferrioxamine

18 May 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

ESTIMATION OF FERRIOXAMINE AND DESFERRIOXAMINE IN URINE.

18 May 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamine

18 May 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload

18 May 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Safety of intensive chelation therapy

18 May 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Reassessment of the Use of Desferrioxamine B in Iron Overload

18 May 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

Cooley anemia: High transfusion regimen and chelation therapy, results, and perspective

18 May 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1979.TB02809.X

18 May 2023

Identifiers

0 references